Back to Search
Start Over
Rate control in atrial fibrillation using Landiolol is safe in critically ill Covid-19 patients.
- Source :
-
Critical care (London, England) [Crit Care] 2021 Jan 22; Vol. 25 (1), pp. 33. Date of Electronic Publication: 2021 Jan 22. - Publication Year :
- 2021
- Subjects :
- Aged
Critical Illness
Female
Hospitalization
Humans
Intensive Care Units
Male
Morpholines adverse effects
Morpholines pharmacology
Patient Safety
Prospective Studies
Treatment Outcome
Urea adverse effects
Urea pharmacology
Urea therapeutic use
Atrial Fibrillation drug therapy
Heart Rate drug effects
Morpholines therapeutic use
Urea analogs & derivatives
COVID-19 Drug Treatment
Subjects
Details
- Language :
- English
- ISSN :
- 1466-609X
- Volume :
- 25
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Critical care (London, England)
- Publication Type :
- Academic Journal
- Accession number :
- 33482867
- Full Text :
- https://doi.org/10.1186/s13054-021-03470-3